TY  - CONF

T1  - Abstract CT123: A randomised phase 2 study of paclitaxel with or without trametinib or pazopanib in advanced wild type BRAF melanoma

JO  - Clinical Trials

PY  - 2017/07/01

AU  - Middleton MR

AU  - Schadendorf D

AU  - Danson S

AU  - Marshall E

AU  - Corrie P

AU  - Love SB

AU  - Mohammed SB

AU  - Scudder C

AU  - Goff M

ED  - 

DO  - DOI: 10.1158/1538-7445.am2017-ct123

PB  - American Association for Cancer Research

Y2  - 2024/09/19

ER  -